FSTX   $7.12  0.0 Market Closed

F-star Therapeutics Inc
Last Events:

2023-03-29 Signal in Stochastic changed from bullish recovery to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

2023-03-29 Signal in MACD changed from bullish to bullish reversal. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

2023-03-29 Signal in RSI changed from bullish weakening to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-03-29 Signal in EMA100 changed from bullish reversal to bearish reversal. 2023-01-26 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

2023-03-29 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-01-26 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-01-24 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-29 Trend Power changed from slow to almost flat.

2023-03-29 Trend changed from turning down to up and flat.


Current temperature: 0.00
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 4.24
Target: 7.00
High with 50% probability: 9.97
Analyst Recommendations:
Number of estimates 3
Target Price Mean 7.00
Mean unverified/preliminary 7.00 / 7.00
Target Price Low / High 7.00 / 7.00
Median / STD DEV 7.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - Buy ActivelyBuy
rsi ActivelyBuy ActivelyBuy ActivelyBuy
macd - - -
stoch - - -
ma20 Sell Buy -
ma50 - - -
ma100 - Buy -
Candlestick PatternMarch 8, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US30315R1077
ceo Dr. Eliot Richard Forster M.B.A., Ph.D.
Website https://www.f-star.com
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom. As of March 8, 2023, F-star Therapeutics, Inc. operates as a subsidiary of invoX Pharma Limited.